{"schema_version":"secwatch.filing_event.v1","accession":"0000875320-26-000166","form_type":"8-K","ticker":"VRTX","cik":"0000875320","company_name":"VERTEX PHARMACEUTICALS INC / MA","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.846171+00:00","generated_at":"2026-05-15T02:36:41.306347+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Vertex director Suketu Upadhyay to depart after annual meeting to become Incyte CFO","bullets":["Upadhyay will not stand for re-election due to scheduling conflicts from his incoming CFO role at Incyte.","He will continue as director until the 2026 annual meeting; board reduces size to ten members.","Proxy materials amended to remove Upadhyay as nominee; previously voted proxies remain valid for other matters.","Departure is not due to any disagreement with Vertex on operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0000875320-26-000166","json":"https://secwatch.observer/filing/0000875320-26-000166.json","markdown":"https://secwatch.observer/filing/0000875320-26-000166.md","text":"https://secwatch.observer/filing/0000875320-26-000166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000166/0000875320-26-000166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000166/vrtx-20260428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:36:41.306347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0113d1e33c","claim":"Suketu Upadhyay departed as Director at VERTEX PHARMACEUTICALS INC / MA.","evidence_excerpt":"Suketu Upadhyay informed the board of directors (the \"Board\") of Vertex Pharmaceuticals Incorporated (the \"Company\") of his decision not to stand for re-election as a director of the Company at the Company’s 2026 annual meeting of shareholders (the \"2026 Annual Meeting\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000166/0000875320-26-000166-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not standing for re-election"},{"label":"Role","value":"Director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}